Mason Chiang
About Mason Chiang
Mason Chiang is an Associate Director at Bristol Myers Squibb with a background in clinical pharmacy, public health, and global health.
Current Role at Bristol Myers Squibb
Mason Chiang currently holds the position of Associate Director at Bristol Myers Squibb. In this role, he leverages his expertise to contribute to diverse health initiatives and the strategic planning of various programs. His work primarily focuses on enhancing patient care and addressing socio-political drivers of health.
Previous Experience at Bristol Myers Squibb
Before becoming Associate Director, Mason Chiang served as Senior Program Manager at Bristol Myers Squibb from 2022 to 2024 in the New York City Metropolitan Area. Prior to that, he was a PGY2 Public Health/PharmD Resident at the same company from 2021 to 2022. During these roles, he gained valuable experience in managing health programs and providing clinical care.
Educational Background
Mason Chiang obtained his Doctor of Pharmacy (Pharm.D.) and Graduate Certificate in Global Health from the University of Washington, where he studied from 2015 to 2019. He also earned a Bachelor's of Science in Biomolecular Sciences from the University of Michigan between 2012 and 2015. Prior to that, he attended Townsend Harris High School from 2008 to 2012.
Past Positions in Healthcare and Research
Mason Chiang's career includes a variety of positions in healthcare and research. He was a PGY1 Acute Care Pharmacy Resident at Sutter Health from 2020 to 2021 in San Francisco and a Bonderman Fellow at UW Bonderman Fellowship from 2018 to 2019. Additionally, he held the position of Thomas J Francis Fellow in 2017 for a short tenure in Phnom Penh, Cambodia. His early career includes roles as an Inpatient Pharmacy Intern at University of Washington Medical Center, Inpatient Pharmacy Technician at VA Ann Arbor Healthcare System, and Research Assistant at The Rosania Research Group.
Passion for Global Health and Social Justice
Mason Chiang is passionate about expanding access to quality patient care both domestically and internationally. His work integrates elements of clinical pharmacy practice, public and global health, social justice, and diversity, equity, and inclusion (DEI). He focuses on strengthening health systems infrastructure to overcome barriers to patient care, aiming to create a more equitable healthcare landscape.